DK171894B1 - 2,3-Disubstitueret isoxazolidin-holdige di- eller tripeptider, deres fremstilling og farmaceutiske præparater deraf - Google Patents

2,3-Disubstitueret isoxazolidin-holdige di- eller tripeptider, deres fremstilling og farmaceutiske præparater deraf Download PDF

Info

Publication number
DK171894B1
DK171894B1 DK662087A DK662087A DK171894B1 DK 171894 B1 DK171894 B1 DK 171894B1 DK 662087 A DK662087 A DK 662087A DK 662087 A DK662087 A DK 662087A DK 171894 B1 DK171894 B1 DK 171894B1
Authority
DK
Denmark
Prior art keywords
opr
gly
alkyl
aryl
obzl
Prior art date
Application number
DK662087A
Other languages
Danish (da)
English (en)
Other versions
DK662087A (da
DK662087D0 (da
Inventor
Stephan Henke
Dietrich Brocks
Volkmar Guenzler
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK662087D0 publication Critical patent/DK662087D0/da
Publication of DK662087A publication Critical patent/DK662087A/da
Application granted granted Critical
Publication of DK171894B1 publication Critical patent/DK171894B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0819Tripeptides with the first amino acid being acidic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK662087A 1986-12-17 1987-12-16 2,3-Disubstitueret isoxazolidin-holdige di- eller tripeptider, deres fremstilling og farmaceutiske præparater deraf DK171894B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863643012 DE3643012A1 (de) 1986-12-17 1986-12-17 2,3-disubstituierte isoxazolidine, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
DE3643012 1986-12-17

Publications (3)

Publication Number Publication Date
DK662087D0 DK662087D0 (da) 1987-12-16
DK662087A DK662087A (da) 1988-06-18
DK171894B1 true DK171894B1 (da) 1997-08-04

Family

ID=6316346

Family Applications (1)

Application Number Title Priority Date Filing Date
DK662087A DK171894B1 (da) 1986-12-17 1987-12-16 2,3-Disubstitueret isoxazolidin-holdige di- eller tripeptider, deres fremstilling og farmaceutiske præparater deraf

Country Status (21)

Country Link
US (2) US5422342A (fi)
EP (1) EP0271865B1 (fi)
JP (1) JP2703912B2 (fi)
KR (1) KR960010349B1 (fi)
AR (1) AR246528A1 (fi)
AT (1) ATE81344T1 (fi)
AU (1) AU599177B2 (fi)
CA (1) CA1338484C (fi)
DE (2) DE3643012A1 (fi)
DK (1) DK171894B1 (fi)
ES (1) ES2052539T3 (fi)
FI (1) FI88303C (fi)
GR (1) GR3006699T3 (fi)
HU (1) HU201961B (fi)
IE (1) IE61034B1 (fi)
IL (1) IL84841A (fi)
NO (1) NO175058B (fi)
NZ (1) NZ222921A (fi)
PH (1) PH24746A (fi)
PT (1) PT86380B (fi)
ZA (1) ZA879400B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818850A1 (de) * 1988-06-03 1989-12-07 Hoechst Ag Oligopeptide mit zyklischen prolin-analogen aminosaeuren
DD284030A5 (de) 1988-11-24 1990-10-31 Hoechst Ag,De Verfahren zur herstellung von peptiden mit bradykinin-antagonistischer wirkung
DE3842197A1 (de) * 1988-12-15 1990-06-21 Hoechst Ag Rasch spaltbares substrat fuer die hiv-protease
DE4016596A1 (de) * 1990-05-23 1991-11-28 Hoechst Ag Ein neues kupplungsreagenz fuer die peptidsynthese
LT3872B (en) 1993-12-06 1996-04-25 Hoechst Ag Novel peptides and pharmaceutical compositions containing them
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
EP0796855B1 (de) 1996-03-20 2002-02-06 Hoechst Aktiengesellschaft Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
FR2746394B1 (fr) 1996-03-20 1998-05-29 Roussel Uclaf Nouveaux composes tricycliques, leur procede de preparation, et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
US5801187A (en) * 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
DE19653647A1 (de) 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
DE19741235A1 (de) 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19741873A1 (de) * 1997-09-23 1999-03-25 Hoechst Marion Roussel De Gmbh Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19751251A1 (de) 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
DE19821483A1 (de) 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
CA2456269A1 (en) * 2001-08-23 2003-03-06 The Government Of The United States Of America Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives
AU2005265131B2 (en) * 2004-06-17 2012-02-23 Infinity Discovery, Inc. Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
US7842815B2 (en) 2004-06-17 2010-11-30 Infinity Pharmaceuticals, Inc. Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
TWI389895B (zh) 2006-08-21 2013-03-21 Infinity Discovery Inc 抑制bcl蛋白質與結合夥伴間之交互作用的化合物及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944562A (en) * 1974-04-17 1976-03-16 The Upjohn Company αS, 4S, 5R α-Amino-3-chloro-4-hydroxy-2-isoxazoline-5-acetic acid
US4269772A (en) * 1980-01-14 1981-05-26 Merck & Co., Inc. Synthesis of thienamycin via trans-3-carboxymethylene-4-carboxy-5-methyl-Δ2 -isoxazoline
DE3002989A1 (de) * 1980-01-29 1981-07-30 Hoechst Ag, 6000 Frankfurt Hydroxyphenyl-thiazol, -thiazolin und -thiazolidin-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des kollagenstoffwechsels
US4562187A (en) * 1985-01-22 1985-12-31 Hoechst-Roussel Pharmaceuticals Inc. (Isoxazol-3-yl)arylmethanones, compositions and pharmaceutical use
DE3643957A1 (de) * 1986-12-22 1988-06-30 Bayer Ag Substituierte n-methylisoxazolidine

Also Published As

Publication number Publication date
AU599177B2 (en) 1990-07-12
DK662087A (da) 1988-06-18
AU8258987A (en) 1988-06-23
IL84841A0 (en) 1988-06-30
HU201961B (en) 1991-01-28
PH24746A (en) 1990-10-01
CA1338484C (en) 1996-07-23
GR3006699T3 (fi) 1993-06-30
EP0271865B1 (de) 1992-10-07
FI88303C (fi) 1993-04-26
DE3782149D1 (fi) 1992-11-12
JPS63165374A (ja) 1988-07-08
NO875263D0 (no) 1987-12-16
PT86380B (pt) 1990-11-20
IE873418L (en) 1988-06-17
NO175058C (fi) 1994-08-24
FI875503A0 (fi) 1987-12-15
ZA879400B (en) 1988-07-27
FI88303B (fi) 1993-01-15
NO175058B (no) 1994-05-16
FI875503A (fi) 1988-06-18
PT86380A (de) 1988-01-01
DE3643012A1 (de) 1988-06-30
ES2052539T3 (es) 1994-07-16
US5422342A (en) 1995-06-06
IE61034B1 (en) 1994-09-07
KR960010349B1 (ko) 1996-07-30
KR880007497A (ko) 1988-08-27
HUT47956A (en) 1989-04-28
NZ222921A (en) 1989-08-29
EP0271865A3 (en) 1990-02-07
EP0271865A2 (de) 1988-06-22
IL84841A (en) 1992-07-15
US5610146A (en) 1997-03-11
JP2703912B2 (ja) 1998-01-26
ATE81344T1 (de) 1992-10-15
AR246528A1 (es) 1994-08-31
DK662087D0 (da) 1987-12-16
NO875263L (no) 1988-06-20

Similar Documents

Publication Publication Date Title
DK171894B1 (da) 2,3-Disubstitueret isoxazolidin-holdige di- eller tripeptider, deres fremstilling og farmaceutiske præparater deraf
CZ38094A3 (en) Novel isosteric peptides
US5206343A (en) Oligopetides with cyclic proline-analogous amino acids
PT92497B (pt) Processo para a preparacao de derivados de ureia de dipeptideos inibidores de enzimas, e de composicoes farmaceuticas que os contem
JPH03502578A (ja) 7/7a因子活性部位阻害剤
JP2002524571A (ja) VIIa因子阻害剤
KR20010086468A (ko) 트롬빈 억제제
CA2005337A1 (en) Use of peptide isosteres as retroviral protease inhibitors
NO176104B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di- og tripeptider
PT93797A (pt) Processo para a preparacao de derivados dipeptidicos com accao inibidora de enzimas e de composicoes farmaceuticas que os contem
AU709088B2 (en) Thrombin inhibitors
AU616071B2 (en) Renin-inhibiting urea derivatives of dipeptides, a process for the preparation thereof, agents containing these, and the use thereof
JPS62265263A (ja) 置換4−アミノ−3−ヒドロキシ酪酸誘導体およびその製造方法
FI75175C (fi) Process foer framstaellning av n-karboxialkylprolin innehaollande tripeptider.
PT92496A (pt) Processo para a preparacao de derivados de dipeptideos com accao inibitoria de enzimas, e de composicoes farmaceuticas que os contem
EP1864994A1 (en) Par-2 agonist
CA2015071A1 (en) Renin-inhibiting dipetides, a process for their preparation, agents containing them and their use
PT649426E (pt) Inibidores de proteases retrovirais
DE3839128A1 (de) Renin-hemmende dipeptide, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK